US Patent # US011107588 – dated Aug 31, 2021
Methods and Systems of Prioritizing Treatments, Vaccination, Testing and/or Activities While Protecting the Privacy of Individuals
This patent details how to select individuals based on whether they are determined to potentially be superspreaders (ie: possibly the unvaxxed?) in order to modify the DOSEAGE of vaxx that should be administered to same ……… ALL examples used are all SARS-COV-2 (COVID-19) related.
Anyone want to take a stab at the science & terminology used in this patent to figure out implications?
On the surface it seems a very convenient way to ensure select individuals receive oversized levels of the vaxx (which would logically lead to outsized reactions) and this patent provides the necessary legal “cover/protection” for those making such decisions. Still this is speculation until someone can interpret the entire patent.
https://pdfpiw.uspto.gov/.piw?